Scinai Immunotherapeutics (SCNI) Non-cash Items (2020 - 2021)
Scinai Immunotherapeutics' (SCNI) quarterly Non-cash Items came in at $1.1 million in Q4 2021, up 461.46% year-over-year from $193779.9 in Q4 2020, and up 461.46% quarter-over-quarter from -$301000.0 in Q4 2020.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) Non-cash Items (2020 - 2021) Analysis & Trends
Scinai Immunotherapeutics has disclosed Non-cash Items across 2 years of filings, most recently posting $1.1 million for Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Scinai Immunotherapeutics | 1.52 Bn | 1.52 Bn | -1.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 1.09 Mn |
| Dec 31, 2020 | -301,000.00 |
| Sep 30, 2020 | -20.31 Mn |